Menu
GeneBe

KIF14

kinesin family member 14, the group of Kinesins

Basic information

Region (hg38): 1:200551496-200620751

Links

ENSG00000118193NCBI:9928OMIM:611279HGNC:19181Uniprot:Q15058AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome (Moderate), mode of inheritance: AR
  • autosomal recessive primary microcephaly (Supportive), mode of inheritance: AR
  • lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome (Supportive), mode of inheritance: AR
  • autosomal recessive primary microcephaly (Definitive), mode of inheritance: AR
  • lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome (Strong), mode of inheritance: AR
  • microcephaly 20, primary, autosomal recessive (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Meckel syndrome 12; Microcephaly 20, primary, autosomal recessiveARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingGenitourinary; Neurologic; Ophthalmologic; Renal24128419; 28892560; 29343805

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KIF14 gene.

  • not provided (2 variants)
  • Microcephaly 20, primary, autosomal recessive (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIF14 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
31
clinvar
9
clinvar
41
missense
130
clinvar
22
clinvar
6
clinvar
158
nonsense
1
clinvar
1
clinvar
2
clinvar
4
start loss
0
frameshift
2
clinvar
3
clinvar
1
clinvar
6
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
3
clinvar
3
clinvar
6
splice region
1
4
4
2
11
non coding
13
clinvar
44
clinvar
57
Total 3 7 138 66 59

Highest pathogenic variant AF is 0.00000657

Variants in KIF14

This is a list of pathogenic ClinVar variants found in the KIF14 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-200553141-G-A Benign (Nov 12, 2018)1283604
1-200553157-C-T Benign (Nov 12, 2018)1265811
1-200553223-A-T Benign (Nov 12, 2018)1286174
1-200553391-C-A Likely benign (Nov 27, 2023)739562
1-200553391-C-T Likely benign (Jan 10, 2024)2910905
1-200553393-C-T Inborn genetic diseases Uncertain significance (Mar 12, 2024)3114469
1-200553413-G-A Inborn genetic diseases Uncertain significance (Nov 07, 2022)2322591
1-200553438-G-C Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome • Microcephaly 20, primary, autosomal recessive Benign (Jan 29, 2024)1223272
1-200553438-GG-CA Likely benign (Sep 19, 2022)1983060
1-200553451-G-A KIF14-related disorder Likely benign (Sep 17, 2019)3039913
1-200553458-T-C Inborn genetic diseases Uncertain significance (Nov 09, 2022)2380083
1-200553464-C-T Inborn genetic diseases • KIF14-related disorder Uncertain significance (Nov 27, 2023)1697001
1-200553465-G-A Inborn genetic diseases Uncertain significance (Dec 01, 2022)2331290
1-200553473-A-G Inborn genetic diseases Uncertain significance (Jun 29, 2021)2231744
1-200553491-C-T Inborn genetic diseases Uncertain significance (May 05, 2023)2544399
1-200553492-C-T Microcephaly 20, primary, autosomal recessive • Inborn genetic diseases Conflicting classifications of pathogenicity (Jan 24, 2024)740813
1-200553493-G-A Microcephaly 20, primary, autosomal recessive;Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome Benign/Likely benign (Jan 09, 2024)721215
1-200553531-T-G Inborn genetic diseases Uncertain significance (Jan 27, 2022)2274215
1-200553545-T-C Uncertain significance (Apr 10, 2023)3006607
1-200553553-C-G not specified • KIF14-related disorder Conflicting classifications of pathogenicity (Jan 29, 2024)435618
1-200553593-C-A Inborn genetic diseases Uncertain significance (Oct 14, 2021)2255438
1-200553593-CA-C Uncertain significance (Mar 11, 2022)2107972
1-200553645-T-C Inborn genetic diseases Uncertain significance (Feb 28, 2023)2491457
1-200553658-A-G Uncertain significance (Aug 01, 2022)2639716
1-200553663-T-C Uncertain significance (Jul 10, 2023)2055338

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KIF14protein_codingprotein_codingENST00000367350 2969235
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00004111.001256540931257470.000370
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7697628240.9250.000040710913
Missense in Polyphen1752290.764183076
Synonymous1.012582800.9230.00001382973
Loss of Function5.632376.00.3030.000003861008

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009160.000790
Ashkenazi Jewish0.000.00
East Asian0.0007260.000707
Finnish0.0001860.000185
European (Non-Finnish)0.0003900.000387
Middle Eastern0.0007260.000707
South Asian0.0003690.000359
Other0.0006520.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Microtubule motor protein that binds to microtubules with high affinity through each tubulin heterodimer and has an ATPase activity (By similarity). Plays a role in many processes like cell division, cytokinesis and also in cell proliferation and apoptosis (PubMed:24784001, PubMed:16648480). During cytokinesis, targets to central spindle and midbody through its interaction with PRC1 and CIT respectively (PubMed:16431929). Regulates cell growth through regulation of cell cycle progression and cytokinesis (PubMed:24854087). During cell cycle progression acts through SCF-dependent proteasomal ubiquitin-dependent protein catabolic process which controls CDKN1B degradation, resulting in positive regulation of cyclins, including CCNE1, CCND1 and CCNB1 (PubMed:24854087). During late neurogenesis, regulates the cerebellar, cerebral cortex and olfactory bulb development through regulation of apoptosis, cell proliferation and cell division (By similarity). Also is required for chromosome congression and alignment during mitotic cell cycle process (PubMed:15843429). Regulates cell spreading, focal adhesion dynamics, and cell migration through its interaction with RADIL resulting in regulation of RAP1A-mediated inside-out integrin activation by tethering RADIL on microtubules (PubMed:23209302). {ECO:0000250|UniProtKB:L0N7N1, ECO:0000269|PubMed:15843429, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:16648480, ECO:0000269|PubMed:23209302, ECO:0000269|PubMed:24784001, ECO:0000269|PubMed:24854087}.;
Disease
DISEASE: Meckel syndrome 12 (MKS12) [MIM:616258]: A form of Meckel syndrome, a disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. {ECO:0000269|PubMed:24128419}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Microcephaly 20, primary, autosomal recessive (MCPH20) [MIM:617914]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH20 features include mild to moderate intellectual disability, autistic features, poor speech. Disease severity is highly variable. {ECO:0000269|PubMed:28892560, ECO:0000269|PubMed:29343805}. Note=The disease is caused by mutations affecting the gene represented in this entry. The disease-causing variant NM_014875.2:c.263T>A, which produces a premature truncation of the protein at Leu-88 (p.Leu88Ter), may also partly result in the deletion of 372 bp of exon 2 of KIF14 by activation of a cryptic splice site. This in-frame deletion predicts a protein that lacks 124 aa (p.Gly58-Leu181del). The disease-causing mutation NM_014875.2:c.3662G>T, resulting in the missence variant p.Gly1221Val, may also induce the skipping of exon 24, resulting in a protein that misses 76 aa (p.Gly1221_ Lys1296delinsVal). {ECO:0000269|PubMed:28892560}.;
Pathway
Signal Transduction;RHO GTPases activate CIT;RHO GTPase Effectors;Signaling by Rho GTPases (Consensus)

Recessive Scores

pRec
0.117

Intolerance Scores

loftool
0.785
rvis_EVS
-0.03
rvis_percentile_EVS
51.42

Haploinsufficiency Scores

pHI
0.0682
hipred
N
hipred_score
0.389
ghis
0.446

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.440

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Kif14
Phenotype
craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
regulation of cell growth;microtubule-based movement;microtubule depolymerization;mitotic metaphase plate congression;positive regulation of cell population proliferation;regulation of G2/M transition of mitotic cell cycle;cerebellar granular layer structural organization;cerebellar Purkinje cell layer structural organization;cerebellar cortex development;hippocampus development;olfactory bulb development;cell proliferation in forebrain;cerebral cortex development;regulation of cell adhesion;regulation of cell migration;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;regulation of myelination;activation of protein kinase activity;positive regulation of cytokinesis;regulation of Rap protein signal transduction;negative regulation of integrin activation;substrate adhesion-dependent cell spreading;negative regulation of apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of neuron apoptotic process;negative regulation of neuron apoptotic process;establishment of protein localization;cell division;regulation of cell maturation;regulation of G1/S transition of mitotic cell cycle
Cellular component
nucleus;cytosol;kinesin complex;microtubule;plasma membrane;membrane;midbody;spindle midzone;Flemming body
Molecular function
microtubule motor activity;protein binding;ATP binding;microtubule binding;ATP-dependent microtubule motor activity, plus-end-directed;tubulin binding;ATPase activity;protein kinase binding;PDZ domain binding